Qatar vs Slovakia: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Qatar
96.0%
in 2025
Slovakia
96.0%
in 2025
Qatar rank
26th
Slovakia rank
26th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Qatar
- Slovakia
How they compare
Qatar currently reports 96.0% against 96.0% in Slovakia, a difference of 0.0%.
The two have swapped places 4 times across 18 shared years of data; in 2008 it was Slovakia ahead.
Qatar ranks 26th and Slovakia ranks 26th of 192 countries.
Across the 3 decades both report, Qatar averaged higher in 1 and Slovakia in 1.
Head to head by decade
| Decade | Qatar | Slovakia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 49.5% | 49.5% | 0.0% | β |
| 2010s | 96.6% | 97.3% | 0.7% | Slovakia |
| 2020s | 97.0% | 96.2% | 0.8% | Qatar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Qatar or Slovakia?
- Qatar, at 96.0% against 96.0% in Slovakia as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Qatar and Slovakia?
- 0.0%, with Qatar ahead.
- How many years of comparable data are there for Qatar and Slovakia?
- 18 years are reported by both, from 2008 to 2025.
- How do Qatar and Slovakia rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Qatar ranks 26th and Slovakia ranks 26th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.